Illumina files patent infringement suit against BGI Europe in Denmark

Illumina said that it has filed a patent infringement lawsuit against BGI Europe, a subsidiary of BGI, in the Maritime & Commercial High Court of Denmark.

According to the complaint, BGI’s sequencing products, including the BGISEQ-500 and MGISEQ-2000 instruments and related sequencing chemistry reagents of BGI subsidiary MGI Tech, infringe Illumina’s European patent EP 3 002 289 B1, which covers sequencing-by-synthesis chemistry.

The complaint also alleges that BGI’s use of the name MGISEQ infringes Illumina’s trademark for the MISEQ name, registered trademark No. 8972127.

This is the second patent infringement lawsuit that Illumina has filed against BGI this year. In March the company sued Latvia MGI Tech, another subsidiary of BGI, in a German court for alleged infringement of Illumina’s European Patent EP 1 530 578 B1, which also covers sequencing-by-synthesis chemistry.